These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy]. Garin N; Nendaz M Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046 [TBL] [Abstract][Full Text] [Related]
5. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. Segreti J; House HR; Siegel RE Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674 [TBL] [Abstract][Full Text] [Related]
6. Approach to therapy of respiratory infections in the critical care setting. Pennington JE Semin Respir Infect; 1990 Sep; 5(3):226-32. PubMed ID: 2255806 [TBL] [Abstract][Full Text] [Related]
7. Outpatient treatment of community-acquired pneumonia in adults. Pomilla PV; Brown RB Arch Intern Med; 1994 Aug; 154(16):1793-802. PubMed ID: 8053746 [TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171 [TBL] [Abstract][Full Text] [Related]
9. Antibiotics for community-acquired pneumonia. Dryden M; Hand K; Davey P; J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250 [TBL] [Abstract][Full Text] [Related]
10. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [TBL] [Abstract][Full Text] [Related]
12. Empiric antibiotic prescribing for patients with community-acquired pneumonia: where can we improve? Buising KL; Thursky KA; Black JF; Macgregor L; Street AC; Kennedy MP; Brown GV Intern Med J; 2008 Mar; 38(3):174-7. PubMed ID: 18290813 [TBL] [Abstract][Full Text] [Related]
15. Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones. Carrie AG; Kozyrskyj AL Can J Clin Pharmacol; 2006; 13(1):e102-11. PubMed ID: 16585811 [TBL] [Abstract][Full Text] [Related]
16. Barriers to the effective management of respiratory tract infections in the community. Saginur R Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Maimon N; Nopmaneejumruslers C; Marras TK Eur Respir J; 2008 May; 31(5):1068-76. PubMed ID: 18216053 [TBL] [Abstract][Full Text] [Related]
18. Pneumonia observational incidence and treatment: a multidisciplinary process improvement study. Brozek J; McDonald E; Clarke F; Gosse C; Jaeschke R; Cook D Am J Crit Care; 2007 May; 16(3):214-9. PubMed ID: 17460312 [TBL] [Abstract][Full Text] [Related]
19. Role of gemifloxacin in community-acquired pneumonia. Tillotson GS Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107 [TBL] [Abstract][Full Text] [Related]
20. [Changes in guidelines for the therapy of non-nosocomial pneumonitis]. Navazio F Clin Ter; 2000; 151(1):25-7. PubMed ID: 10822878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]